With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeted Inhibition of Signaling Networks in Pediatric Glioblastoma Stem Cells||University of California Berkeley / Erin Simonds, PhD||Young Investigator Grants||2013||California|
|Targeted Inhibition of the DNA Damage Response Pathway: A Novel Intervention in the Treatment of Pediatric Leukemias||National Cancer Institute / Andre Nussenzweig, Ph.D.||Reach Grants||2014||Maryland|
|Targeted Polymeric Parthenolide Carriers to Treat Childhood AML||University of Rochester / Danielle Benoit||Young Investigator Grants||2010||New York|
|Targeted regulation of acetylation as novel therapy for Ewing sarcoma.||Georgetown University / Jeffrey Toretsky||Innovation Grants||2009||District of Columbia|
|Targeted Therapy for Core Binding Factor Leukemia||University of Massachusetts Medical School / John Pulikkan, PhD||Young Investigator Grants||2014||Massachusetts|
|Targeting a Novel Epigenetic Signature in Diffuse Intrinsic Pontine Gliomas||New York University School of Medicine / Danny Reinberg, PhD||Reach Grants||2019||New York|
|Targeting Aberrant Hh Signaling with BET Bromodomain Inhibition as a Novel Therapeutic Strategy Against MB and DIPG||Lucile Packard Children's Hospital at Stanford University School of Medicine / Yujie Tang, PhD||Young Investigator Grants||2014||California|
|Targeting BRD9 in Sarcoma||Dana-Farber Cancer Institute / Scott Armstrong, MD/PhD||Innovation Grants||2017||Massachusetts|
|Targeting Childhood Brain Cancer in a Dish to Catalyze New Therapies||University of California, Davis Medical Center / Paul Knoepfler, PhD||Innovation Grants||2017||California|
|Targeting Chondroitin Sulphate Proteoglycan 4 (CSPG4) in Glioblastoma||University of North Carolina / Gianpietro Dotti, MD & Barbara Savoldo, MD/PhD||Reach Grants||2017||North Carolina|